Boehringer Ingelheim Santé Animale France

Boehringer Ingelheim Santé Animale France est membre de Lyonbiopôle

General information

29 avenue Tony Garnier

69007 Lyon

Incorporated in: 2017/01/01

Number of employees: 2300

Turnover: €860M (in 2016)

More information


Main activity

As the second largest animal health business in the world, Boehringer Ingelheim is committed to improving animal health. With more than 10,000 employees worldwide, Boehringer Ingelheim Animal Health has products available in more than 150 markets and a global presence in 99 countries.  Boehringer Ingelheim provides advanced, preventive animal healthcare. We develop vaccines, parasiticides and pharmaceuticals that protect animals against disease and pain. And we develop new therapies to help those who care for animals to manage chronic diseases more effectively, limiting pain and slowing down disease progression. In France, our headquarters for Amimal Health are located in Lyon Gerland. We have 2 R&D sites (Lyon and St Vulbas) and 4 production sites (Lyon Porte-des- Alpes,Lentilly, Toulouse, Saint-Herblon) For more information, please visit or


Strategic area of application
Veterinary Medicine

Application market
Cardiology - Infectiology - Parasitology - Others

Therapeutics, Pharma or Biotech - Diagnostics

Vaccine - Others